Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tandem Diabetes Care, Inc. - Common Stock
(NQ:
TNDM
)
22.60
+0.49 (+2.22%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tandem Diabetes Care, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
April 03, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
3 Reasons to Sell TNDM and 1 Stock to Buy Instead
March 26, 2025
Shareholders of Tandem Diabetes would probably like to forget the past six months even happened. The stock dropped 54.1% and now trades at $20.22. This was partly driven by its softer quarterly results...
Via
StockStory
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
March 19, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 4 Experts
↗
February 27, 2025
Via
Benzinga
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Unveiling 8 Analyst Insights On Tandem Diabetes Care
↗
December 02, 2024
Via
Benzinga
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
March 18, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
3 Healthcare Stocks Walking a Fine Line
March 18, 2025
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...
Via
StockStory
Topics
Stocks
This H.B. Fuller Company Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
↗
March 05, 2025
Via
Benzinga
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 5 Experts
↗
November 06, 2024
Via
Benzinga
Which stocks are experiencing notable movement on Thursday?
↗
February 27, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
Which stocks are moving on Thursday?
↗
February 27, 2025
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
These stocks are gapping in today's session
↗
February 27, 2025
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Tandem Diabetes Crashes 32% As Light Outlook Rattles Pump-Maker's Shares
↗
February 27, 2025
Shares hit their lowest point since January 2024 after the stock market opened Thursday.
Via
Investor's Business Daily
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
February 27, 2025
Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Via
Chartmill
These stocks are moving in today's after hours session
↗
February 26, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Tandem Diabetes’s (NASDAQ:TNDM) Q4 Sales Beat Estimates But Stock Drops 12.2%
February 26, 2025
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 35% year on year to $282.6 million. The company expects next quarter’s...
Via
StockStory
Topics
Earnings
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance
February 26, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
February 25, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect
February 25, 2025
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect.
Via
StockStory
Tandem Diabetes Care Announces Upcoming Conference Presentations
February 13, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
January 15, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
January 07, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
December 10, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
↗
December 02, 2024
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via
Benzinga
Tandem Diabetes Care Announces Upcoming Conference Presentations
November 21, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
November 06, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Participation
October 30, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
↗
October 04, 2024
Via
Benzinga
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
October 02, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today